Medical Countermeasures Smallpox Preparedness Contracts Top $60 Million as U.S. and International Partners Bolster Biodefense StockpilesGlobal Biodefense StaffMarch 25, 2026
Industry News U.S. Government Expands Smallpox Stockpile With $54 Million VIGIV Contract, International Orders Add $6.6 MillionGlobal Biodefense StaffMarch 25, 2026
Medical Countermeasures Mpox Antiviral Clinical Trial Advances as WHO Extends Global EmergencyGlobal Biodefense StaffJuly 17, 2025
Achaogen Gets Federal Funding for Biowarfare Agent Therapeutic Development Contracts + Grants October 9, 2017 …
First Plant-Based Seasonal Flu Vaccine Candidate Reaches Final Clinical Stage Industry News September 26, 2017 …
Pandemic Preparedness: Seqirus Quadruples Manufacturing Output for Flu Vaccine Industry News August 29, 2017 …
BARDA Awards 46M for Treatment System that Cleans Pathogens from Blood Contracts + Grants May 18, 2017 …
Emergent Unveils Expanded CIADM Facility for Medical Countermeasure Preparedness Biosecurity May 16, 2017 …
Soligenix Receives Japanese Patent for Vaccine Heat Stabilization Technology Industry News May 9, 2017 …
Battelle and Nanotherapeutics Form Alliance to Accelerate Medical Countermeasures Development CBRNE April 5, 2017 …
NIAID-Backed Phase 1b Study to Evaluate Broad-Spectrum Antiviral for Dengue Featured News February 1, 2017 …
PaxVax Announces Partnership with NIH and DOD for Chikungunya Vaccine Program Defense + Military January 10, 2017 …
MRIGlobal Awarded Contract for Mycobacterium Tuberculosis Quality Assessment Program Biodetection January 10, 2017 …
